We know that chemotherapy works in killing cancer cells. The dilemma in conventional oncology is whether the high doses of chemotherapy used over time will kill the patient before it kills the cancer. High dose chemotherapy often carries with it significant toxicity symptoms affecting multiple organ systems including digestive organs, the brain, heart, and lungs. This is why many patients feel much worse after starting chemotherapy than they did before treatment began. Sadly, the toxicity burden can weigh heavily on patients’ bodies, resulting in significant collateral damage, poor quality of life, and death.
Insulin potentiation therapy, known as IPT, is a procedure whereby low doses of chemotherapy are given on a more frequent basis. By administering safe doses of insulin along with specific chemotherapeutic agents, the chemotherapy is preferentially taken up by cancer cells due to those cells’ unique physiology. The doses of chemotherapy used in IPT are usually about 10-20% of the amount used by most oncologists in conventional treatment. Lower doses of chemotherapy mean that:
- The body’s healthy cells are exposed to significantly less chemotherapy
- The incidence and severity of side effects such as nausea, vomiting, fatigue, and hair loss are much lower
- The body’s immune system is stronger
- Quality of life is generally better
Dr. Stegall views IPT as a heat-seeking missile, precisely targeted with very little collateral damage. Contrast this with conventional high dose chemotherapy, which is analogous to the atom bomb which results in widespread damage.
Many people who are not familiar with IPT believe that it must be a new therapy. However, it was actually developed in the 1930s by Donato Perez Garcia, MD to treat syphilis. He soon realized that it could be effective in other diseases as well, and began using it successfully to treat cancer patients. Sadly, IPT has not caught on in mainstream medicine circles, although it is certainly a top treatment used by most integrative cancer physicians. Dr. Stegall feels that it is a vital component of virtually all cancer treatment protocols.